Gilenya (je-LEN-yah, fingolimod) is the first ORAL drug to reduce relapses in relapsing-remitting multiple sclerosis (MS)

Gilenya (je-LEN-yah, fingolimod) is the first ORAL drug to reduce relapses in relapsing-remitting multiple sclerosis (MS).

It's an immune modulator and might help prevent white blood cells from entering the CNS and damaging it.

But don't expect to see Gilenya used first-line.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote